1. Inicio
2. INVESTIGACIÓN
3. Proxectos
4. A new family of anticancer drugs: selective cleavage of DNA three-way junctions by CU(II) peptide helicates acting as nucleases

A new family of anticancer drugs: selective cleavage of DNA three-way junctions by CU(II) peptide helicates acting as nucleases

Entidade Financiadora: 

Fundación AECC - Ideas Semilla 2021

Ref.: 

IDEAS211154VÁZQ

Duración: 

2021-2023

Investigador principal: 

Miguel Vázquez

Grupo de investigación: 

Vázquez López / Vázquez Sentís